Results 51 to 60 of about 30,877 (270)

A krónikus szívelégtelenség epidemiológiája, a kezelési lehetőségek, a bisoprolol helye a terápiás palettán [PDF]

, 2013
The prevalence of chronic heart failure in Hungary is 1.6% in the adult population, but it occurs in 15-20% of subjects over 80 years of age. The base of treatment of heart failure is the blockade of the neuro-hormonal system, which includes the use of ...
Nagy, Viktor
core   +1 more source

Chemoenzymatic Protocol for the Synthesis of Enantiopure β-Blocker (S)-Bisoprolol

Catalysts, 2022
The β-blocker (S)-bisoprolol hemifumarate has been synthesised in 96% enantiomeric excess with 19% total yield in a six-step synthesis. A transesterification reaction of the racemic chlorohydrin 1-chloro-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2 ...
Lucas Bocquin, E. Jacobsen
semanticscholar   +1 more source

EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY

Рациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate effect of bisoprolol on circadian blood pressure (BP) profile, autonomic cardiovascular regulation, lipid and carbohydrate metabolism in young patients with arterial hypertension (HT) and obesity. Materials and methods. 36 men aged 18 to
A. G. Avtandilov, I. I. Esenova, S. L. Petrosov   +2 more
doaj   +1 more source

Autonomic modulation in patients with heart failure increases beat-to-beat variability of ventricular action potential duration [PDF]

, 2017
Background: Exaggerated beat-to-beat variability of ventricular action potential duration (APD) is linked to arrhythmogenesis. Sympathetic stimulation has been shown to increase QT interval variability, but its effect on ventricular APD in humans has not
Behar, Jonathan, Bishop, Martin J., Claridge, Simon, Gill, Jaswinder S., Gould, Justin, O'Neill, Mark, Porter, Bradley, Razavi, Reza, Rinaldi, Christopher A., Sieniewicz, Benjamin J., Taggart, Peter, Webb, Jessica   +11 more
core   +2 more sources

Patient-friendly extemporaneous formulation of bisoprolol: application to stability and bioavailability studies

Drug Delivery and Translational Research, 2022
Community and hospital pharmacists always face the challenge to prepare oral liquid extemporaneous formulations to fit the needs of a specific patient population when commercial forms or the required strength is unavailable.
Soha M. El-masry, S. Helmy, SohaA.M. Helmy, Eman A. Mazyed   +3 more
semanticscholar   +1 more source

Comparative effectiveness of bisoprolol and carvedilol among patients receiving maintenance hemodialysis

Clinical Kidney Journal, 2021
Background Despite widespread use, there is no trial evidence to inform β-blocker’s (BB) relative safety and efficacy among patients undergoing hemodialysis (HD).
P. Wu, Yi-Ting Lin, Jia-Sin Liu, Yi-Chun Tsai, M. Kuo, Y. Chiu, Shang-Jyh Hwang, J. Carrero   +7 more
semanticscholar   +1 more source

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms [PDF]

, 2014
Aim In the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), aldosterone blockade with eplerenone decreased mortality and hospitalisation in patients with mild symptoms (New York Heart Association class II ...
Akehurst, R., Cowie, M.R., Krum, H., Lee, D., McMurray, J.J.V., Pitt, B., van Veldhuisen, D.J., Vincent, J., Wilson, K., Zannad, F.   +9 more
core   +3 more sources

Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension

Clinical and Experimental Hypertension, 2020
β blockers (BBs) play an important role in heart failure (HF) treatment. However, orthostatic hypotension (OH) is sometimes caused by BBs. The bisoprolol transdermal patch works more slowly and is long acting compared with the bisoprolol fumarate tablet.
Shunsuke Kiuchi, Shinji Hisatake, Takayuki Kabuki, Takashi Oka, Shintaro Dobashi, Takahiro Fujii, Takahide Sano, Takanori Ikeda   +7 more
doaj   +1 more source

Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses [PDF]

, 2017
Peer ...
Donner, Kati M., Fyhrquist, Frej, Hiltunen, Timo P., Kontula, Kimmo K., Mohney, Rob, Rimpelä, Jenni M., Sarin, Antti-Pekka, Stirdivant, Steven, Tuiskula, Annukka M.   +8 more
core   +1 more source

Beta-blockers in COPD:time for reappraisal [PDF]

, 2016
The combined effects on the heart of smoking and hypoxaemia may contribute to an increased cardiovascular burden in chronic obstructive pulmonary disease (COPD).
Devereux, Graham, Dransfield, Mark T., Lipworth, Brian, Vestbo, Jørgen, Wedzicha, Jadwiga   +4 more
core   +3 more sources